Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01701817 · ClinicalTrials.gov registry record
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 13,769
- Enrollment target
NCT01701817: Completed study, sponsored by Janssen Scientific Affairs.
NCT01701817 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 13,769 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01701817 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 13,769 participants
- Enrollment target
Study Summary
The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is a multicenter, prospective outpatient disease registry to evaluate the utilization of target-specific antithrombotic agents, such as FXa (factor Xa) inhibitors and direct thrombin inhibitors, and associated outcomes. Importantly, the ORBIT AF II registry will permit the collection and analysis of post-approval observational data needed for evaluating the outcomes associated with these new agents when used in broader patient populations outside of clinical studies. The ORBIT-AF II registry will focus on patients with newly diagnosed atrial fibrillation (AF) as well as those who have been recently started on a target-specific oral anticoagulant agent. Taken together, the ORBIT-AF I and ORBIT-AF II registries will offer a broad and contemporary view of AF therapy.
Primary Outcome
Major bleeding will be defined according to International Society of Thrombosis and Hemostasis (ISTH) criteria.
Interventions
- OTHER Patients with Atrial Fibrillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,769 participants |
| Start Date | 2013-02-20 |
| Est. Completion | 2017-07-12 |
What the finished NCT01701817 record still lists
NCT01701817 is an observational study that tracks outcomes without assigning an intervention. Its 13,769 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Patients with Atrial Fibrillation is the first listed.
NCT01701817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01701817 about?
NCT01701817 is a clinical study titled "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)". The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is a multicenter, prospective outpatient disease registry to evaluate the utilization of target-specific antithrombotic agents, such as FXa (factor Xa) inhibitors and direct thrombin inhibitors, and associated o...
What is the current status of trial NCT01701817?
This trial is currently completed. The enrollment target is 13,769 participants. The study started on 2013-02-20. Estimated completion is 2017-07-12.
What interventions are being tested in trial NCT01701817?
The interventions under investigation include: Patients with Atrial Fibrillation (OTHER).
Who is sponsoring clinical trial NCT01701817?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI